Gilles L Fraser1, Richard R Riker. 1. Division of Pulmonary and Critical Care Medicine, Maine Medical Center, Portland, ME 04102, USA. fraseg@mmc.org
Abstract
PURPOSE OF REVIEW: To review the recent advances in providing analgesia and sedation to intensive care unit patients that can improve outcomes, and reduce resource utilization and adverse events. RECENT FINDINGS: Validated tools to assess patient sedation and analgesia are available, and have been shown to improve outcomes when used. A strategy providing analgesia-first and supplemented by sedation-as-needed appears to improve patient outcomes. The negative impact of deep sedation to the point of coma, even for brief periods, is again recognized. Additional data defining adverse events associated with propofol and lorazepam can help us develop strategies to avoid them. SUMMARY: Utilizing and incorporating these new advances can improve outcomes and result in a more comfortable patient.
PURPOSE OF REVIEW: To review the recent advances in providing analgesia and sedation to intensive care unit patients that can improve outcomes, and reduce resource utilization and adverse events. RECENT FINDINGS: Validated tools to assess patient sedation and analgesia are available, and have been shown to improve outcomes when used. A strategy providing analgesia-first and supplemented by sedation-as-needed appears to improve patient outcomes. The negative impact of deep sedation to the point of coma, even for brief periods, is again recognized. Additional data defining adverse events associated with propofol and lorazepam can help us develop strategies to avoid them. SUMMARY: Utilizing and incorporating these new advances can improve outcomes and result in a more comfortable patient.
Authors: Mary Jo Grap; Virginia A Hamilton; Ann McNallen; Jessica M Ketchum; Al M Best; Nyimas Y Isti Arief; Paul A Wetzel Journal: Heart Lung Date: 2010-08-17 Impact factor: 2.210
Authors: Daniel W Wheeler; Andrew J Thompson; Federico Corletto; Jill Reckless; Justin C T Loke; Nicolas Lapaque; Andrew J Grant; Pietro Mastroeni; David J Grainger; Claire L Padgett; John A O'Brien; Nigel G A Miller; John Trowsdale; Sarah C R Lummis; David K Menon; John S Beech Journal: PLoS One Date: 2011-02-24 Impact factor: 3.240
Authors: Ralph Schneider; Andreas Puetz; Timon Vassiliou; Thomas Wiesmann; Ulrike Lewan; Hinnerk Wulf; Detlef K Bartsch; Caroline Rolfes Journal: Indian J Crit Care Med Date: 2017-05
Authors: Giovanni Mistraletti; Elena S Mantovani; Paolo Cadringher; Barbara Cerri; Davide Corbella; Michele Umbrello; Stefania Anania; Elisa Andrighi; Serena Barello; Alessandra Di Carlo; Federica Martinetti; Paolo Formenti; Paolo Spanu; Gaetano Iapichino Journal: Trials Date: 2013-04-03 Impact factor: 2.279